Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review

Monoclonal antibody therapies have secured an important role in the therapeutic landscape for the treatment of both relapsing and progressive forms of multiple sclerosis due to their potent efficacy, convenient dosing schedules, and well-defined side effect profiles. Each therapy has unique risks an...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsbernd, Paul M, Carter, Jonathan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255409/
https://www.ncbi.nlm.nih.gov/pubmed/34234409
http://dx.doi.org/10.2147/BTT.S267273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255409/
https://www.ncbi.nlm.nih.gov/pubmed/34234409
http://dx.doi.org/10.2147/BTT.S267273

Ejemplares similares